Clearstead Advisors’s Korro Bio KRRO Stock Holding History

Clearstead Advisors’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18	Closed	-$863	–	3026
2025 Q3	$863	Buy	+18	New	+$399	﹤0.01%	2645

Other funds holding KRRO

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

7IH

72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Clearstead Advisors's KRRO Position: Q4 2025 in Review

Clearstead Advisors sold out of Korro Bio (KRRO) in Q4 2025, closing a stake of 18 shares — an estimated $863 sold.

Clearstead Advisors first reported a position in KRRO in Q3 2025 and held it in 1 quarter. The position peaked at $863 in Q3 2025. 83 funds tracked by Wall St. Rank hold KRRO as of Q4 2025.

Clearstead Advisors reported no remaining Korro Bio position as of Q4 2025 after selling out during the quarter.
Clearstead Advisors sold 18 Korro Bio shares in Q4 2025, an estimated $863.
Clearstead Advisors first reported a position in Korro Bio in Q3 2025 and held it in 1 quarter.
Clearstead Advisors's Korro Bio position peaked at $863 in Q3 2025.
83 funds tracked by Wall St. Rank held Korro Bio as of Q4 2025.

Based on Clearstead Advisors's 13F filing for Q4 2025, filed 9 Feb 2026.